CAH Stock Down Nearly 9.4% YTD: Should You Buy, Hold or Sell?

CAH shares are down 9.4% YTD, but strong specialty drug growth, rising earnings estimates and a raised outlook may signal upside.

Zacks Investment Research • May 14, 2026

Cardinal Health Was Supposed to Beat UnitedHealth. Did It? Will It?

Roughly a year ago, 24/7 Wall St. ran a piece titled Forget UnitedHealth.

24/7 Wall Street • May 14, 2026

Cardinal Health, Inc. (CAH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Cardinal Health, Inc. (CAH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • May 13, 2026

Can CAH Sustain Growth on Booming Pharmaceutical & Specialty Segment?

Cardinal Health's CAH Pharmaceutical & Specialty Solutions segment continues to be the primary engine of enterprise growth, delivering another standout quarter in the third quarter of fiscal 2026. Segment revenues climbed 19% to approximately $61 billion, while segment profit increased 29%, underscoring the segment's growing importance to Cardinal Health's earnings profile.

Zacks Investment Research • May 13, 2026

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • May 11, 2026

Down 14.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Cardinal (CAH)

The heavy selling pressure might have exhausted for Cardinal (CAH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Zacks Investment Research • May 8, 2026

Here's Why Cardinal Health (CAH) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • May 8, 2026

Brokers Suggest Investing in Cardinal (CAH): Read This Before Placing a Bet

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks Investment Research • May 7, 2026

Here's Why Cardinal Health (CAH) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • May 7, 2026

Cardinal Health Board of Directors Approves Quarterly Dividend

DUBLIN, Ohio, May 5, 2026  /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend to $0.5158 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2026 to shareholders of record at the close of business on July 1, 2026.

PRNewsWire • May 5, 2026